Therapeutic effect of myogenic cells modified to express neurotrophic factors in a rat model of sciatic nerve injury

Journal of Stem Cells and Regenerative Medicine

Volumn 8, Issue 1, 2012, Pages

  Dadon Nachum, Michal ^a   Ben Zur, T ^a   Srugo, I ^b   Shamir, H M ^b   Melamed, E ^a   Yaffe, D ^c   Offen, D ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CELL PROTECTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; IN VIVO STUDY; MOTONEURON; MUSCLE ACTION POTENTIAL; MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SCIATIC NERVE INJURY; THERAPY EFFECT;

RATTUS;

EID: 84863537137     PISSN: 09737154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004; 429 (6990): 413-7.
2. Crone SA, Lee KF. Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems. Ann. N. Y. Acad. Sci.2002; 971: 547-53.
3. Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N, Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. cell Biol. 2005;168(2): 193-9.
4. Li W, Brakefield D, Pan Y, Hunter D, Myckatyn TM, sParsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 2007; 203(2): 457-71.
5. Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Geneti. 2001; 27(2): 195-200.
6. Rabinovsky ED, Gelir E, Gelir S, Lui H, Kattash M, DeMayo FJ, Shenaq SM, Scheartz RJ. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 2003; 17(1):53-5.
7. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Dh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005; 8(1): 85-92.
8. Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J. Neurosci. 2007; 27(2): 304-7.
9. Zheng C, Sköld MK, Li J, Nennesmo I, Fadeel B, Henter JI. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Biochem. Biophys. Res. Commun. 2007; 363(4): 989-93.
10. Fryer HJ, Wolf DH, Knox RJ, Strittmatter SM, Pennica D, O'Leary RM, Russell DS, Kalb RG. Brain-derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway. J. Neurochem. 2000; 74 (2): 582-95.
11. Hu P, Kalb RG. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB. J. Neurochem. 2003; 84(6): 1421-30.
12. Mousavi K, Parry DJ, Jasmin BJ. BDNF rescues myosin heavy chain IIB muscle fibers after neonatal nerve injury. Am. J. Physiol. 2004; 287(1): C22-9.
13. Ozdinler PH, Macklis JD. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat. Neurosci. 2006; 9(11): 1371-81.
14. Zhang J, Luo X, Xian C, Liu Z, Zhou X. BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. Eur. J. Neurosci. 2000;12(12):4171-4180.
15. Goel R K, Suri V, Suri A, Sarkar, Mohanty S, Sharma MC, Yadav PK, Srivastava A. Effect of bone marrow-derived mononuclear cells on nerve regeneration in the transection model of the rat sciatic nerve. J. Clin. Neurosci. 2009; 16(9), 1211-1217.
16. Dadon-Nachum M, Sadan O, Srugo I, Melamed E, Offen D. Differentiated mesenchymal stem cells for sciatic nerve injury. Stem Cell Rev. 2011; Epub ahead of print.
17. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS study group. Ann. Neurol. 1996; 39 (2): 256-60.
18. Stender M. Gene therapy for motor neuron disease. Nat. Med.1997; 3 (4); 380-1.
19. Yaffe D. Cellular aspects of muscle differentiation in vitro. Curr. Top. Dev. Biol. 1969; 4: 37-77.
20. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature, 1977; 270 (5639): 725-7.
21. Yaffe D, Saxel O. A myogenic cell line with altered serum requirements for differentiation. Differentiation,1977; 7:159-66.
22. Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine, 2008; 33 (22):2464-2472.
23. Acsadi G, Anguelov R, Yang H, Toth G, Thomas R, Jani A, Wang Y, Ianakova E, Mohammad S, Lewis RA, Shy ME. Increased survival and function of SOD1 mice after Glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 2002; 10 (13):1047-1059.
24. Mohajeri H, Figlewicz D, Bohn M. Intramuscular grafts of myoblasts genetically modified to secrete glial cell linederived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther.1999; 10: 1853-1866.
25. Pan HC, Yang DY, Chiu YT, Lai SZ, Wang YC, Chang MH, Cheng FC. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cells. J. Clin. Neurosci. 2006; 13: 570-575
26. Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, Chang MH, Ho SP. Post injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J. Clin. Neurosci. 2007; 14: 1089-1098.
27. Logan A, Ahmed Z, Baird A, Gonzalez AM, Berry M. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain, 2006; 129: 490-502.
28. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Annu. Rev. Neurosci. 1990; 13:43-60.
29. Gu S, Shen Y, Xu W, Xu L, Li X, Zhou G, Gu Y, Xu J. Application of fetal neural stem cells transplantation in delaying denervated muscle atrophy in rats with peripheral nerve injury. Microsurgury, 2010; 30(4); 266-74
30. Hall, S. (2001). Nerve repair: a neurobiologist's view. Journal of Hand Surgery, 26:129-36.
31. Rochkind S, Geuna S, Shainberg A. Phototherapy in peripheral nerve injury: effects on muscle preservation and nerve regeneration. In Int. Rev. Neurobiol. New York. 2009; PP: 445-64
32. Amoh Y, Kanoh M, Niiyama S, Hamada Y, Kawahara K, Sato Y, Hoffman RM, Katsuoka K. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. J. Cell. Biochem. 2009; 107(5); 1016-20.
33. Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone marrow stromal cells. Eur. J. Neurosi. 2001;14; 1771-6.
34. Santiago LY, Clavijo-Alvarez J, Brayfield C, Rubin JP, Marra KG. Delivery of adipose derived precursors cells for peripheral nerve repair. Cell Tranplant. 2009; 18(2); 145-58.
35. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 2003; 8 (301); 839-42.